Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY

Published on September 16, 2021

Thermo Fisher (TMO) gains FDA pre-market approval for Oncomine Dx as companion diagnostic for Takeda's EXKIVITY.

Continue reading on website
Other news

5 Textile - Apparel Stocks to Buy on Splendid Industry Patterns

September 16, 2021
The Zacks Textile - Apparel industry participants are benefiting from reviving brick-and-mortar traffic and solid e-commerce trends. Robust digital ef...

Is Teekay (TGP) a Suitable Stock for Value Investors Now?

September 16, 2021
Let's see if Teekay (TGP) stock is a good choice for value-oriented investors right now from multiple angles.